Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 14 | Cooper Jeffrey ElliottChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $144K 994 sh |
| Sep 21, 2026 traded Sep 18, 2026 |
| 14 | Kuzoyan VaheDirector, President | Derivative conversion | C | — 3,148 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 14 | Cooper Jeffrey ElliottChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $120K 854 sh | Sep 21, 2026 traded Sep 18, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $19K 80 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 13 | Hohl BenjaminCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $177K 3,535 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $28K 120 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 13 | Bowen Julie MarieDirector | Grant or award | A | $13K 3,197 sh | Sep 21, 2026 traded Sep 21, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $29K 120 sh | Sep 21, 2026 traded Sep 18, 2026 |
| 13 | Raman PrakashDirector | Grant or award | A | $13K 6,801 sh | Sep 21, 2026 traded Sep 18, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $32K 131 sh | Sep 21, 2026 traded Sep 18, 2026 |
| 13 | Siegel Andrew DavidDirector | Grant or award | A | — 6,594 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $30K 120 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 13 | Baker Christopher J.Director, See Remarks | Option exercise | M | — 38.9K sh | Sep 21, 2026 traded Sep 21, 2026 |
| 13 | Collins Helen LouiseCHIEF MEDICAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $94K 1,844 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $19K 80 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $28K 120 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 13 | Hohl BenjaminCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $111K 2,194 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 13 | Collins Helen LouiseCHIEF MEDICAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $146K 2,916 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $19K 80 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 13 | Kirchhoff Benjamin LouisCHIEF ACCOUNTING OFFICER | Open-market sale · 10b5-1 plan | SELL | $31K 770 sh | Sep 21, 2026 traded Sep 18, 2026 |
| 12 | Malpani RaghavendraCPO & CTO | Open-market sale · 10b5-1 plan | SELL | $567K 40.5K sh | Sep 21, 2026 traded Sep 17, 2026 |
| 12 | Fichera AlfredDirector | Grant or award | A | $62K 3,483 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 11 | Sousa Mauad BrunoDirector | Derivative conversion | C | $6.05M 208.4K sh | Sep 21, 2026 traded Sep 18, 2026 |
| 11 | Rosenbaum Michael GeorgeDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $175K 1,200 sh | Sep 21, 2026 traded Sep 21, 2026 |
| 10 | Akinsanya KarenSee Remarks | Option exercise · 10b5-1 plan | M | $137K 31.6K sh | Sep 21, 2026 traded Sep 17, 2026 |
| 9 | Parry GrahamChief Scientific Officer | Derivative conversion | C | — 85.5K sh | Sep 21, 2026 traded Sep 21, 2026 |
| 9 | Di Beasi AlisaSVP and CHRO | Grant or award | A | — 32 sh | Sep 21, 2026 traded Sep 18, 2026 |
| 9 | McMullen JamesController | Grant or award | A | — 3 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 9 | Bunch John MarkCOO | Grant or award | A | — 45.6K sh | Sep 21, 2026 traded Sep 17, 2026 |
| 9 | Ding AdrianChief Financial Officer | Grant or award | A | — 134 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 9 | DING JerryChief People Officer | Grant or award | A | — 25 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 9 | Zhang LeilaChief Technology Officer | Grant or award | A | — 22 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 9 | LIU PingpingChief Legal Officer | Grant or award | A | — 9 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 9 | Stagliano NancyDirector | Derivative conversion | C | — 255.6K sh | Sep 21, 2026 traded Sep 21, 2026 |
| 9 | DING JerryChief People Officer | Option exercise | M | — 9 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 9 | Lu XuelingController and PAO | Grant or award | A | — 27 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 9 | Fischer JamieChief Operating Officer | Tax withholding | F | $676 380 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 9 | DING JerryChief People Officer | Tax withholding | F | $207 5 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 9 | DING JerryChief People Officer | Grant or award | A | — 2 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 9 | Wat JoeyDirector, Chief Executive Officer | Grant or award | A | — 612 sh | Sep 21, 2026 traded Sep 17, 2026 |